Veracyte (VCYT) Depreciation & Amortization (CF) (2012 - 2026)

Veracyte has disclosed Depreciation & Amortization (CF) across 15 years of filings, most recently posting $5.4 million for Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $5.4 million, up 1.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $21.5 million (down 7.52% YoY), and the FY2025 annual result was $21.4 million, down 8.71% from the prior year.
• Depreciation & Amortization (CF) came in at $5.4 million for Q1 2026 at Veracyte, up from $5.3 million in the prior quarter.
• In the past five years, Depreciation & Amortization (CF) ranged from a high of $7.3 million in Q3 2023 to a low of $5.3 million in Q3 2025.
• The 5-year median for Depreciation & Amortization (CF) is $6.3 million (2024), against an average of $6.1 million.
• Across the five-year window, Depreciation & Amortization (CF) soared 157.1% in 2022 and retreated 19.73% in 2024, its largest moves.
• Veracyte's Depreciation & Amortization (CF) stood at $6.6 million in 2022, then slipped by 3.36% to $6.3 million in 2023, then slipped by 1.31% to $6.3 million in 2024, then dropped by 15.27% to $5.3 million in 2025, then gained by 2.49% to $5.4 million in 2026.
• The last three Depreciation & Amortization (CF) figures came in at $5.4 million (Q1 2026), $5.3 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.